-
HMGCS2-Mediated Lipid Metabolism Drives Pulmonary Fibrosis
2026-06-16
Yang et al. identify that downregulation of HMGCS2 in alveolar epithelial cells disrupts lipid metabolism, leading to lysophospholipid accumulation and fibroblast activation in pulmonary fibrosis. This mechanistic insight offers new targets for intervention and advances the understanding of lipid signaling in fibrotic lung disease.
-
Propidium iodide: Reliable DNA Intercalating Dye for Cell An
2026-06-16
Propidium iodide is a robust DNA intercalating dye widely used for cell viability assays and apoptosis detection. It selectively stains cells with compromised membranes and provides high-contrast, reproducible results in flow cytometry and microscopy. APExBIO’s formulation (SKU B7758) offers consistent performance and stability for demanding biomedical workflows.
-
Optimizing DOT1L Inhibition: EPZ5676 for MLL Leukemia Workfl
2026-06-15
EPZ5676 delivers unmatched selectivity and nanomolar potency for dissecting H3K79 methylation in MLL-rearranged leukemia models. This article translates bench data into actionable protocols, troubleshooting, and advanced applications, empowering researchers to leverage APExBIO’s EPZ5676 for robust, reproducible epigenetic and cytotoxicity assays.
-
Nilotinib (AMN-107): Mechanistic Leverage for Translational
2026-06-15
Explore how Nilotinib (AMN-107) reshapes translational kinase research by integrating deep mechanistic insight, robust protocol guidance, and a vision for next-generation targeted therapy development. This article advances beyond standard product narratives, tying conformational kinase regulation to actionable strategies in chronic myeloid leukemia and gastrointestinal stromal tumor research.
-
Fluconazole as a Fungal Cytochrome P450 Inhibitor: Protocols
2026-06-14
Fluconazole's role as a fungal cytochrome P450 enzyme 14α-demethylase inhibitor makes it indispensable for dissecting antifungal resistance and modeling Candida albicans infections. This article bridges state-of-the-art host-pathogen research with actionable workflows, troubleshooting guidance, and advanced applications to accelerate fungal pathogenesis studies.
-
Technical Guide: Omeprazole (A2845) for Gastric Acid Researc
2026-06-13
Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor designed for research on gastric acid secretion and antiulcer mechanisms. It is suitable for controlled in vitro and preclinical workflows, but is not appropriate for diagnostic, therapeutic, or clinical applications.
-
Optimizing mRNA Delivery: EZ Cap™ Firefly Luciferase mRNA in
2026-06-12
Discover how EZ Cap™ Firefly Luciferase mRNA advances mRNA delivery and translation efficiency assays, leveraging recent breakthroughs in lipid nanoparticle design. This article provides a unique, in-depth analysis of structure–function insights and practical protocols for robust, reproducible bioluminescent assays.
-
3-Bromopyruvate and Cetuximab Synergy: Overcoming CRC Resist
2026-06-12
This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab induces autophagy-dependent ferroptosis and apoptosis, overcoming resistance in colorectal cancer cell lines with KRAS or BRAF mutations. The findings illuminate a mechanistically distinct strategy to target refractory metastatic colorectal cancer.
-
Neuromedin S (rat): Technical Use and Workflow Parameters
2026-06-11
Neuromedin S (rat) provides a chemically defined peptide agonist for precise activation of neuromedin U receptor signaling in rat GPCR/G protein studies. It addresses the need for reproducible, validated ligands in controlled research on energy homeostasis, stress response, and circadian rhythm pathways. This product is not suitable for diagnostic or therapeutic applications.
-
MTT: Precision in Cell Viability and Metabolic Activity Assa
2026-06-11
Leverage the reliability of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) for high-sensitivity, reproducible colorimetric cell viability assays. This guide details optimized workflows, real-world applications, and troubleshooting strategies that transform APExBIO’s MTT into a gold-standard solution for quantitative in vitro research.
-
Dual-Mode Tracking: EZ Cap™ Cy5 EGFP mRNA (5-moUTP) in Next-
2026-06-10
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables simultaneous visualization and functional readout in gene delivery research. This article uniquely integrates machine learning-driven insights and dual fluorescence tracking to guide advanced mRNA delivery assay design.
-
CB-839 (Telaglenastat): Advancing Glutaminolysis Inhibition
2026-06-10
CB-839 (Telaglenastat) provides researchers with a highly selective and reversible tool for dissecting glutamine metabolism in cancer models. This article details applied workflows, troubleshooting strategies, and unique insights from recent epitranscriptomic research, setting a new standard for preclinical cancer metabolism studies.
-
Azithromycin in Translational Research: Mechanism, Models, a
2026-06-09
Explore how Azithromycin, a macrolide antibiotic, empowers translational researchers with precise mechanistic insight and advanced model design. This thought-leadership article bridges rigorous mechanistic understanding to actionable workflow guidance, benchmarking resistance, and translational relevance—offering unique, evidence-driven strategy beyond standard product descriptions.
-
Lambda Protein Phosphatase (RNase-free): Reliable Phosphoryl
2026-06-09
This article delivers a scenario-driven, evidence-based exploration of Lambda Protein Phosphatase (RNase-free), APExBIO SKU K1102, focusing on its pivotal role in enhancing reproducibility and data quality in phosphorylation-dependent assays. By addressing real laboratory challenges, it demonstrates how K1102 streamlines the validation of phospho-specific antibodies and functional analyses in cell viability, proliferation, and circadian biology research.
-
HOXC8 Suppresses Pyroptosis in NSCLC by Regulating Caspase-1
2026-06-08
This study uncovers how HOXC8, a homeobox transcription factor, suppresses pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by downregulating caspase-1 expression. The findings clarify a novel epigenetic mechanism linking tumorigenesis and inflammation, with implications for apoptosis and inflammation research.